Important: Retatrutide is an investigational drug. This means that it is not FDA approved at this time and has not been proven safe or effective for any use. Please note it is not prescribed, offered, or available through Midi Health. Midi Health visits cannot be used to obtain retatrutide. This blog article is for information purposes only.
While some online pharmacies may claim to sell retatrutide, the only legal way to receive it today is as a participant in a clinical trial. This investigational medication is still being studied and is not FDA approved, so it is not available via prescription. But we understand why you may be looking for how to get retatrutide. Keep reading to learn more about retatrutide’s regulatory status, the research underway, and FDA-approved care options to discuss with a clinician.
Heard a lot about retatrutide lately? Retatrutide is an investigational medication being studied in adults with obesity, including people with type 2 diabetes. It’s not FDA approved and has not been proven safe or effective for any use. It’s different from currently approved GLP-1 medications: Retatrutide is a triple agonist, meaning it targets three different hormone receptors, rather than one or two.
Lilly has reported results from several phase 3 trials of retatrutide, called TRIUMPH. Some results have not yet been peer reviewed or published, and FDA has not reviewed any of this data.
Beyond obesity, retatrutide is being studied in people with type 2 diabetes, sleep apnea, and knee osteoarthritis, and in studies of heart and kidney outcomes.
Retatrutide is still in clinical trials and is not FDA approved, so it's not available to be prescribed. It’s not available through Midi Health. But if you go online, you’ll find some websites selling retatrutide peptides, even though it’s not approved and cannot be legally sold.
Read on for more about what that means and how retatrutide clinical trials work. We’ll also cover FDA-approved options to discuss with a clinician.
What Is Retatrutide?
Similar to other GLP-1 medications, retatrutide is an injectable medication that targets hormone receptors in your body that directly impact metabolism and appetite. Specifically, retatrutide targets three different receptors:
- GLP-1: helps regulate appetite and blood sugar
- GIP: supports insulin response
- Glucagon: affects energy use and fat metabolism
Researchers are studying how acting on all three receptors may affect digestion, appetite, and food intake. Areas under study in clinical trials include:
- weight loss
- glycemic control (aka how well your blood sugar is managed)
- blood pressure and cholesterol markers
In clinical trials, the most commonly reported retatrutide side effects have been gastrointestinal (GI) issues, similar to other medications in this category, like:
- nausea
- diarrhea
- constipation
- vomiting
Retatrutide’s long-term safety has not been established, and it has not been proven safe or effective for any use.
Is Retatrutide Legal? What About ‘Retatrutide Peptide’ Sold Online?
You may have seen retatrutide peptides or “reta” vials being sold online, but this is being done unlawfully. These peptides for weight loss may be labeled with things like "for research use only" or "not for human consumption" and are often shipped as a powder, but these loopholes are unlawful.
So, if your search history is filled with questions like “Is retatrutide FDA approved?,” let us clear up any confusion: No, retatrutide is not yet FDA approved and cannot be legally compounded or sold commercially.
In other words, there is no legal retatrutide prescription you can get right now, and it is not available outside of a clinical trial. And it’s easy to see why these gray-market reta peptides should be avoided: There’s no way to know for sure what the vial actually contains or how sterile it is.
The FDA is trying to fight this by sending warning letters to retatrutide peptide sellers, but that hasn’t stopped them completely. Remember: Outside of a clinical trial, retatrutide is not available.
When Will Retatrutide Be Available?
While there’s no firm date set yet, retatrutide’s manufacturer, Lilly, announced on July 23, 2026, that it plans to submit the drug to the FDA for approval in the first quarter of 2027. FDA review typically takes about a year (although this timeline could vary). This means that, if it is approved, the earliest retatrutide will be available is likely late 2027 or 2028.
In addition to the exact availability date, a lot remains unknown about retatrutide coming to market. This includes whether it will be approved, what the brand name will be, how much it will cost, and which conditions, if any, it’s ultimately approved for (Lilly has studied it in obesity, diabetes, sleep apnea, and knee osteoarthritis).
But that doesn't mean you're out of luck. FDA-approved weight management medications are available today for eligible patients (more on those in a minute).
How to Get Retatrutide With a Clinical Trial
The pivotal clinical trials on retatrutide (TRIUMPH-1 through TRIUMPH-4) have finished, so enrollment in clinical trials is now limited to smaller or follow-up studies.
Where retatrutide clinical trials are listed
Clinicaltrials.gov lists clinical trials on retatrutide. The site is a longstanding, government-run database of human clinical trials that are happening worldwide.
You’ll be able to find clinical trials at all different phases, including:
- new, not yet recruiting
- active, recruiting
- active, not recruiting
- completed
One thing to note: As of November 2026, the website listed only three retatrutide studies still looking for participants. And keep in mind that though the site is maintained by The National Library of Medicine, the government doesn’t review or approve the safety of all the clinical trials.
That’s why it’s important to speak with a healthcare professional before applying to enroll in a study. A clinician can help you understand the risks of participating. Even if you are a candidate to be in a clinical trial and are selected to be in it, you are not guaranteed to get retatrutide.
You should also go over all medications you currently take with a clinician, such as glucose-lowering diabetes medications, blood pressure or thyroid medications, or anticoagulants. Medications in this class can slow the emptying of your stomach, which can affect how certain oral medications are absorbed.
If you are considering a clinical trial, here is what the process generally involves:
Step 1: Review retatrutide trial listings
Public clinical trial registries, like clinicaltrials.gov, show each study’s recruitment status. You can typically find retatrutide trials by searching for terms such as:
- “retatrutide”
- “triple-agonist obesity trial”
- “investigational metabolic drug study”
From there, you’ll see a list of results. Filter for trials that are recruiting or enrolling. If you are interested in participating but don't see any open trials, keep an eye on ones that are not yet recruiting, as you may be a candidate for them in the future.
Step 2: Review the trial details carefully
Not surprisingly, criteria for clinical trials can be very specific. Before applying, you’ll want to take note of any of the following to make sure the study makes sense for you, your health history, and your lifestyle. Pay close attention to:
- inclusion and exclusion criteria
- location (some trials require in-person visits)
- frequency of check-ins
- study design, including whether the study is randomized and placebo-controlled (a placebo-controlled trial means not everyone receives the medication, which is an important consideration)
- study duration (if you’re in the placebo group, this is how long you’ll go without treatment, too!)
For instance, some retatrutide clinical trials are enrolling people with obesity only, which means you must be above a certain BMI to qualify. Other studies may be looking at retatrutide’s effects on other health conditions, so they might need people with conditions like metabolic dysfunction-associated steatotic liver disease.
Step 3: Apply and complete screening
Each trial listing names a study sponsor and contact. The study team, not Midi Health, decides who is eligible to enroll.
If you do apply, you’ll typically go through:
- a medical history review
- lab work and vital signs
- a consent process explaining risks and benefits
This is your opportunity to ask questions and decide whether participation feels right for you.
Risks Associated With Participating in a Retatrutide Clinical Trial
The risks of participating in a retatrutide clinical trial are the same as for any clinical trial. Because the medication is still being studied, there will always be known and unknown risks. In clinical trials to date, the most commonly reported side effects included:
- nausea
- diarrhea
- vomiting
- constipation
As noted above, in many of these randomized trials, there is a chance that you’d be receiving a placebo, meaning no active drug at all. So, if you want to get moving on your goals as soon as possible, the risk of delaying other effective treatments until the duration of the study is completed may not be worth it.
Other side effects included decreased appetite and dysesthesia (aka unusual skin sensations). Side effects were reported more often at higher doses.
Before enrolling in a clinical trial, you’ll receive detailed information through an informed consent process, so you can weigh all the pros and cons of participating. Don’t be afraid to ask a lot of questions and get a second opinion on joining.
Why GLP-1s May Help With Menopausal Weight Gain
For many women, weight gain is one of the most frustrating changes during perimenopause and menopause—especially as hormones shift and metabolism slows. As estrogen levels decline, women may burn 250 to 300 fewer calories per day, making weight gain easier and weight loss harder.
Menopause is also linked to increased belly fat (aka meno belly), which carries greater health risks. Lower estrogen, reduced activity over time, and menopause-related sleep disruption often work together to drive steady weight gain—about 1.5 pounds per year on average after menopause.
Excess abdominal fat is associated with higher inflammation and increased risk of insulin resistance, high blood pressure, and cardiovascular disease, which is why many menopausal women consider GLP-1 medications as part of a broader, clinician-guided weight management plan.
Working with a healthcare professional who understands your hormone needs is important. Any approach to sustained weight loss should be multifaceted, encompassing various elements that contribute to your overall well-being. So while diet and exercise are important, so are steps like addressing hormones, reducing stress, and prioritizing sleep.
Retatrutide Alternatives for Weight Loss
If you don’t qualify for a retatrutide clinical trial or aren’t chosen to participate, that doesn’t mean you’re out of options. In fact, several evidence-based weight loss treatments are available right now, many with strong clinical data and real-world use behind them. For many people, these options can be effective and more accessible while newer medications like retatrutide are still being studied.
And for those doing well on a currently available GLP-1, there is no clinical reason to switch to retatrutide via a clinical trial right now. You also don’t need to enroll in a retatrutide clinical trial if you’re seeking more modest weight loss to optimize your health. Other care solutions can do the trick.
FDA-approved GLP-1 medications available now
Certain GLP-1 medications are already FDA approved for chronic weight management in eligible adults. In clinical trials, average weight loss has varied by medication and dose.
These medications work by:
- reducing appetite
- increasing feelings of fullness
- improving blood sugar regulation
Because the medications are FDA approved, clinicians have a much clearer understanding of appropriate dosing, common side effects, and long-term safety than they do with investigational drugs like retatrutide.
FDA-approved GLP-1 medications for weight management include:
- Semaglutide: Wegovy (FDA approved for weight loss and cardiovascular risk reduction)
- Tirzepatide: Zepbound (FDA approved for weight management and obstructive sleep apnea)
- Orforglipron: Foundayo (FDA approved for weight loss)
These medications—available as injectables or oral tablets—are available by prescription for eligible patients, where clinically appropriate.
While some of these medications may come with high price tags, many have less expensive vial and self-pay programs that can bring down the cost. Be honest with your healthcare professional about your budget and whether you have insurance, so they can guide you toward the right medication for your needs. (A clinician can help determine the right option for your health, your goals, and your wallet.)
Non-GLP-1 evidence-based weight and metabolic treatments
Weight gain—especially in midlife—is rarely just about willpower. Hormones, insulin resistance, medications, sleep deprivation, stress, and muscle loss all play a role. Depending on your health history, a clinician may consider options like:
- Hormone therapy: Hormone replacement therapy (HRT, now commonly referred to as menopause hormone therapy, or MHT) is not a weight loss drug, but it may help some women with menopause symptoms that affect sleep and mood. This may make it easier to keep up healthy habits, like exercising and eating well.
- Metformin: This long-studied prescription medication is FDA approved for type 2 diabetes, and a clinician may discuss it for insulin resistance when clinically appropriate.
- Contrave: This non-GLP-1 medication is FDA approved for chronic weight management in eligible adults and works on appetite and reward pathways. Many people have reported that it can "help quiet food noise."
Not everyone needs or tolerates a GLP-1. For some people, non-GLP-1 medications, alone or in combination, may be an option when chosen thoughtfully with clinician guidance.
Holistic approaches
Medications work best when they’re paired with foundational care. Chronic sleep deprivation, unmanaged stress, and the wrong type of exercise for your body can actively block weight loss, even if you’re taking medication. Evidence shows that:
- Improving sleep can lower hunger hormones and cortisol.
- Stress management can reduce abdominal fat buildup.
- Strength training helps preserve muscle and boosts metabolic rate over time.
These approaches may not sound flashy, but they’re often what separates short-term weight loss from results that actually last. When the foundation is strong, medications and supplements are more likely to work the way they’re intended to.
The bottom line: While retatrutide may end up being a promising tool for weight loss, it is still being studied, is not FDA approved, and has not been proven safe or effective. Working with a knowledgeable healthcare professional can help you find an appropriate plan using currently available options.
Key Takeaways
- Retatrutide is an investigational drug being studied in clinical trials, and it is not FDA approved. Its manufacturer is planning on submitting retatrutide to the FDA for approval at the beginning of 2027. So, if it is approved, it likely won’t be available until late 2027 or 2028 at the earliest.
- Currently, retatrutide is available only to participants in clinical trials, which are listed on registries such as clinicaltrials.gov. It is not available through Midi Health. Any website or individual claiming to sell retatrutide outside of a trial is not doing so legally or in compliance with safety regulations.
- Sustainable weight loss often requires a clinician-guided, multi-factor approach: Weight gain is influenced by hormones, insulin resistance, sleep, stress, and muscle loss—not just appetite. Combining medications (GLP-1 or non-GLP-1), if eligible, hormone support when appropriate, and lifestyle strategies may support better long-term results.
Frequently Asked Questions (FAQs)
Are you guaranteed retatrutide in a clinical trial?
No, you’re not automatically guaranteed to get retatrutide in a clinical trial. Most trials are randomized and blinded, meaning some participants receive retatrutide, while others get a placebo that doesn’t include the active ingredients. In double-blind studies, neither you nor the study team knows which you’re receiving during the trial. This is essential for high-quality research, but it’s important to be comfortable with that uncertainty.
How can I get retatrutide today?
Retatrutide is not FDA approved. It is available through clinical trials only (although most are no longer enrolling). It cannot be prescribed by a clinician, dispensed by a pharmacy, or legally sold online, and it is not available through Midi Health. Any website or individual claiming to sell retatrutide peptides outside of a trial is not offering a lawfully procured product. Because these supplies bypass regulated pathways, there are no systematic guarantees regarding product quality or safety.
Retatrutide vs. tirzepatide?
Retatrutide and tirzepatide are often compared because they represent the next wave of metabolic medications, but they’re not equally accessible.
Tirzepatide is FDA approved (for diabetes and weight loss, depending on the drug) and works as a dual-agonist, targeting GLP-1 and GIP receptors to reduce appetite, improve insulin response, and support weight loss.
Retatrutide, by contrast, is still investigational and available only through clinical trials. It goes one step further as a triple-agonist, targeting GLP-1, GIP, and glucagon receptors, which may enhance fat metabolism. Early trial data suggest retatrutide could lead to greater average weight loss than tirzepatide, but its long-term safety, side effects, and real-world tolerability are still being studied. These medications haven’t been compared in a head to head study, either.
How long does retatrutide take to kick in?
While the data is not final and we will need more information to assess, the phase 2 clinical trials showed that 4 weeks after starting retatrutide, some people had already lost almost 5% of their body weight.
What weight loss results were observed in clinical trials of retatrutide?
This also depends on how your body reacts to the medication, but preliminary findings from phase 2 clinical trials showed that after 24 weeks (around 6 months), the average participant taking the highest dose of retatrutide lost close to 18% of their body weight. More recent preliminary findings from phase 3 clinical trials show that participants taking the highest dose of retatrutide lost an average of 25% of their body weight over 80 weeks. Please note that these results are based on the clinical trial data only, are not final, and may not reflect the results of future studies or individual outcomes. Retatrutide has not yet received final regulatory approval, and these findings should not be interpreted as a guarantee of results.
What if I only need to lose a small amount of weight?
Because retatrutide is not approved, it is not known who it may be appropriate for. For eligible patients, FDA-approved weight management medications are available, and your choice can depend on factors like insurance coverage, your preferred formulation (an injection versus oral pill), and ease of access and use.
If approved, should I talk to my doctor about whether retatrutide may be appropriate for me?
Early studies suggest retatrutide may be an option for some individuals seeking assistance with weight management, though results from ongoing clinical trials are needed to more fully characterize the drug’s profile and identify which patient populations may derive the greatest benefit. If you have not responded to other weight loss medications or have experienced a plateau in your weight loss progress, you may wish to speak with a qualified healthcare professional to determine whether enrollment in a clinical trial for retatrutide could be appropriate for your individual circumstances.
Is retatrutide legal in the USA?
While it’s legal for people to take retatrutide as part of a clinical trial, it’s not legal to prescribe or sell retatrutide in other ways. It can be dangerous to buy online retatrutide peptides, as these are unregulated drugs, and there’s no way to know what you’re actually getting.
Can I get a prescription for retatrutide?
At the moment, no, you can’t get a prescription for retatrutide (outside of a clinical trial). If retatrutide is FDA approved (likely not before late 2027 or 2028), it may become available by prescription for patients who qualify. For now, healthcare professionals can prescribe other FDA-approved GLP-1s, if eligible and if one is right for you.
Who can get retatrutide?
Since retatrutide is not FDA approved yet, there aren’t specifics about who can get a prescription. That said, when the drug is approved, its prescription requirements may be similar to other GLP-1s for weight loss: those who have obesity or who are overweight with another weight-related condition.
What is the cheapest GLP-1 drug I can buy without insurance?
Prices vary, depending on your insurance provider and what savings programs are in place, but at the moment, opting for a self-pay vial option or signing up for a savings plan through the manufacturer can help bring down your price.
How much will retatrutide cost?
Unless and until retatrutide is approved by the FDA and becomes available in pharmacies, it’s not known how much it will cost. Current FDA-approved GLP-1s can cost as low as $25 for a month’s supply for some insured patients using manufacturer savings programs, or $1,000 or more without insurance or savings plans.
Midi’s mission is to revolutionize healthcare for women at midlife, wherever they live and whatever their health story. We believe that starts with education, to help all of us understand our always-changing bodies and health needs. Our core values guide everything we do, including standards that ensure the quality and trustworthiness of our content and editorial processes. We’re committed to providing information that is up-to-date, accurate, and relies on evidence-based research and peer-reviewed journals. For more details on our editorial process, see here.





